Molecular Pharmacology Ltd (MLPH)

[e-ore]

What would a company be worth if it's line of already developed, different, patented, proven skin care and pain relief products were launched in this country, backed by the endorsement of a world-famous dermatologist? Hard to say; it depends on availability and subsequent volume, but what if the products were rolled out at Walgreens at it's 7000+ stores? MLPH would be worth considerably more than it's current $2 million market cap. Have you checked their financials? Way more liabilities than assets but the liabilities are monies advanced by the parent company and not the typical toxic financing you see in penny stocks so I'm not worried about that. With a very low effective O/S count (80% owned by the parent company, Pharmanet), we'll have a flyer here when product launch is announced. Latest info from the parent company is that "leads are being followed up." The leads are from Dr. Perry Robins' Dermatology Development Corporation (DDC) discussions with "third parties." What makes this special is that neither DDC nor MLPH has to come up with any major money to develop, manufacture, or roll out the products. The way the deal is structured DDC will get royalties from sales. All that has to happen is for the "third parties" to agree to order and sell the products, which already exist.